TITLE

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies

AUTHOR(S)
Kropff, Barbara; Burkhardt, Christiane; Schott, Juliane; Nentwich, Jens; Fisch, Tanja; Britt, William; Mach, Michael
PUB. DATE
October 2012
SOURCE
PLoS Pathogens;Oct2012, Vol. 8 Issue 10, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Herpes viruses persist in the infected host and are transmitted between hosts in the presence of a fully functional humoral immune response, suggesting that they can evade neutralization by antiviral antibodies. Human cytomegalovirus (HCMV) encodes a number of polymorphic highly glycosylated virion glycoproteins (g), including the essential envelope glycoprotein, gN. We have tested the hypothesis that glycosylation of gN contributes to resistance of the virus to neutralizing antibodies. Recombinant viruses carrying deletions in serine/threonine rich sequences within the glycosylated surface domain of gN were constructed in the genetic background of HCMV strain AD169. The deletions had no influence on the formation of the gM/gN complex and in vitro replication of the respective viruses compared to the parent virus. The gN-truncated viruses were significantly more susceptible to neutralization by a gN-specific monoclonal antibody and in addition by a number of gB- and gH-specific monoclonal antibodies. Sera from individuals previously infected with HCMV also more efficiently neutralized gN-truncated viruses. Immunization of mice with viruses that expressed the truncated forms of gN resulted in significantly higher serum neutralizing antibody titers against the homologous strain that was accompanied by increased antibody titers against known neutralizing epitopes on gB and gH. Importantly, neutralization activity of sera from animals immunized with gN-truncated virus did not exhibit enhanced neutralizing activity against the parental wild type virus carrying the fully glycosylated wild type gN. Our results indicate that the extensive glycosylation of gN could represent a potentially important mechanism by which HCMV neutralization by a number of different antibody reactivities can be inhibited.
ACCESSION #
83695635

 

Related Articles

  • Herpesvirus Glycoproteins Undergo Multiple Antigenic Changes before Membrane Fusion. Glauser, Daniel L.; Kratz, Anne-Sophie; Stevenson, Philip G. // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Herpesvirus entry is a complicated process involving multiple virion glycoproteins and culminating in membrane fusion. Glycoprotein conformation changes are likely to play key roles. Studies of recombinant glycoproteins have revealed some structural features of the virion fusion machinery....

  • Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins. Beck, Alain; Wagner-Rousset, Elsa; Bussat, Marie-Claire; Lokteff, Maryline; Klinguer-Hamour, Christine; Haeuw, Jean-Fran�ois; Goetsch, Liliane; Wurch, Thierry; Van Dorsselaer, Alain; Corva�a, Nathalie // Current Pharmaceutical Biotechnology;Dec2008, Vol. 9 Issue 6, p482 

    Monoclonal antibodies (MAbs) are the fastest growing class of human pharmaceuticals. More than 20 MAbs have been approved and several hundreds are in clinical trials in various therapeutic indications including oncology, inflammatory diseases, organ transplantation, cardiology, viral infection,...

  • Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family. Bennett, Eric P; Mandel, Ulla; Clausen, Henrik; Gerken, Thomas A; Fritz, Timothy A; Tabak, Lawrence A // Glycobiology;Jun2012, Vol. 22 Issue 6, p736 

    Glycosylation of proteins is an essential process in all eukaryotes and a great diversity in types of protein glycosylation exists in animals, plants and microorganisms. Mucin-type O-glycosylation, consisting of glycans attached via O-linked N-acetylgalactosamine (GalNAc) to serine and threonine...

  • A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. Wenbo Wang; Jianhui Nie; Prochnow, Courtney; Truong, Carolyn; Zheng Jia; Suting Wang; Xiaojiang S. Chen; Youchun Wang // Retrovirology;2013, Vol. 10 Issue 1, p1 

    Background: Glycans on the human immunodeficiency virus (HIV) envelope glycoprotein (Env) play an important role in viral infection and evasion of neutralization by antibodies. In this study, all 25 potential N-linked glycosylation sites (PNGS) on the HIV-1 CRF07_BC Env, FE, were mutated...

  • Glycosylation as a strategy to improve antibody-based therapeutics. Jefferis, Roy // Nature Reviews Drug Discovery;Mar2009, Vol. 8 Issue 3, p226 

    To date, more than 20 recombinant immunoglobulin G (IgG) antibody therapeutics are licensed for the treatment of various diseases. The mechanism of action of recombinant monoclonal antibodies (rMAbs) has been extensively investigated and several distinct pathways have been defined; selective...

  • Structure of the Epstein-Barr virus major envelope glycoprotein. Szakonyi, Gerda; Klein, Michael G.; Hannan, Jonathan P.; Young, Kendra A.; Ma, Runlin Z.; Asokan, Rengasamy; Holers, V. Michael; Chen, Xiaojiang S. // Nature Structural & Molecular Biology;Nov2006, Vol. 13 Issue 11, p996 

    Epstein-Barr virus (EBV) infection of B cells is associated with lymphoma and other human cancers. EBV infection is initiated by the binding of the viral envelope glycoprotein (gp350) to the cell surface receptor CR2. We determined the X-ray structure of the highly glycosylated gp350 and defined...

  • Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPase. Shapiro, Jason M.; Chung, Waihong; Ogawa, Kosuke; Barker, Luke; Carlson, Rolf; Wands, Jack R.; Li, Jisu // PLoS ONE;11/1/2016, Vol. 11 Issue 10, p1 

    We previously isolated AF20, a murine monoclonal antibody that recognizes a cell surface glycoprotein of approximately 90–110 kDa. The AF20 antigen is specifically expressed in human hepatoma and colon cancer cell lines, and thus could serve as a cancer biomarker. To uncover the molecular...

  • The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct. Learmonth, G. S.; Love, D. N.; Wellington, J. E.; Gilkerson, J. R.; Whalley, J. M. // Archives of Virology;Mar2002, Vol. 147 Issue 3, p607 

    Summary. The unusual mucin-like high molecular mass (Mr) glycoprotein 2 (gp2) has only been described in the equid alphaherpesviruses, among which there is considerable antigenic cross-reactivity. Equine herpesvirus 1 (EHV-1) gp2 is cleaved into a highly glycosylated N-terminal subunit and a 42...

  • A CHIMERIC ANTIBODY AS A CANDIDATE OF A STANDARD FOR ASSAYS TO DETECT IgA ANTICARDIOLIPIN AND ANTI-β2-GLYCOPROTEIN I ANTIBODIES.  // Lupus;Jan2001 Supplement 1, Vol. 10, pS63 

    An abstract of the study "A Chimeric Antibody as a Candidate of a Standard for Assays to Detect IgA Anticardiolipin and Anti-ß2-Glycoprotein I Antibodies" is presented. It discusses the importance of anticardiolipin antibodies and anti-ß2-glycoprotein I antibodies of IgA class. A chimeric...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics